Radicava – Talk Bio

Actionable Insights Powered by AI

Shionogi Announces $2.5 Billion Acquisition of ALS Drug Radicava from Tanabe Pharma

2 days ago talkbio0Tagged ALS, Amyotrophic Lateral Sclerosis, Infrequent, Radicava, shionogi, Tanabe Pharma

Shionogi; Tanabe Pharma; Radicava; ALS; acquisition; $2.5B; rare disease